Type 2 diabetes susceptibility gene variants predispose to adult-onset autoimmune diabetes

Diabetologia

Volumn 57, Issue 9, 2014, Pages 1859-1868

  Andersen, Mette K ^a,b   Sterner, Maria ^c   Forsén, Tom ^a   Käräjämäki, Annemari ^d,e   Rolandsson, Olov ^f   Forsblom, Carol ^a,b,g   Groop, Per Henrik ^a,b,g,h   Lahti, Kaj ^d   Nilsson, Peter M ^c   Groop, Leif ^a,c   Tuomi, Tiinamaija ^a,b,g  

^a UNIVERSITY OF HELSINKI   (Finland)

^b FOLKHÄLSAN RESEARCH CENTER   (Finland)

^c LUND UNIVERSITY   (Sweden)

^d Vasa Health Care Center   (Finland)

^e VAASA CENTRAL HOSPITAL   (Finland)

^f UMEÅ UNIVERSITY   (Sweden)

^g HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^h BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

Adult onset type 1 diabetes; GAD autoantibodies; GADA; Genetics; HNF1A; LADA; Latent autoimmune diabetes in adults; MTNR1B; TCF7L2; ZMIZ1

Indexed keywords

AUTOANTIBODY; CDKAL1 PROTEIN; CYCLIN DEPENDENT KINASE; GLUTAMATE DECARBOXYLASE ANTIBODY; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HHEX PROTEIN; KLHDC5 PROTEIN; MTNR1B PROTEIN; POTASSIUM CHANNEL KCNQ1; PROTEIN; PROTEIN P53; PROX1 PROTEIN; TP53INP1 PROTEIN; TRANSCRIPTION FACTOR 7 LIKE 2; UNCLASSIFIED DRUG; ZMIZ1 PROTEIN; C PEPTIDE; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; GLUCOSE; GLUTAMATE DECARBOXYLASE; HEMOGLOBIN A1C; HLA DQB1 ANTIGEN; TRANSCRIPTION FACTOR;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNE DISEASE; CASE CONTROL STUDY; CONTROLLED STUDY; DIABETIC PATIENT; FEMALE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HIGH RISK PATIENT; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LATENT AUTOIMMUNE DIABETES; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTICENTER STUDY (TOPIC); NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; IMMUNOLOGY; METABOLISM; BODY MASS; DISEASE ASSOCIATION; DISEASE DURATION; FINN (CITIZEN); GLUCOSE BLOOD LEVEL; LATENT AUTOIMMUNE DIABETES MELLITUS; ONSET AGE; SWEDISH CITIZEN;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS;

EID: 84905569151     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-014-3287-8     Document Type: Article

References (47)

1. Turner R, Stratton I, Horton V, et al. (1997) UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group. Lancet 350:1288-1293
2. Tuomi T, Carlsson A, Li H, et al. (1999) Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 48:150-157
3. Hawa MI, Kolb H, Schloot N (2013) Adult-onset autoimmune diabetes in Europe is prevalent with a broad clinical phenotype: action LADA 7. Diabetes Care 36:908-913
4. Davis TM, Wright AD, Mehta ZM, et al. (2005) Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70). Diabetologia 48:695-702
5. van Deutekom AW, Heine RJ, Simsek S (2008) The islet autoantibody titres: their clinical relevance in latent autoimmune diabetes in adults (LADA) and the classification of diabetes mellitus. Diabet Med 25:117-125
6. Tuomi T, Santoro N, Caprio S, Cai M, Weng J, Groop L (2013) The many faces of diabetes: a disease with increasing heterogeneity. Lancet 383:1084-1094
7. Groop L, Pociot F (2014) Genetics of diabetes - are we missing the genes or the disease? Mol Cell Endocrinol 382:726-739
8. Howson JM, Rosinger S, Smyth DJ, et al. (2011) Genetic analysis of adult-onset autoimmune diabetes. Diabetes 60:2645-2653
9. Andersen MK, Lundgren V, Turunen JA, et al. (2010) Latent autoimmune diabetes in adults differs genetically from classical type 1 diabetes diagnosed after the age of 35 years. Diabetes Care 33:2062-2064
10. Klinker MW, Schiller JJ, Magnuson VL, et al. (2010) Single-nucleotide polymorphisms in the IL2RA gene are associated with age at diagnosis in late-onset Finnish type 1 diabetes subjects. Immunogenetics 62:101-107
11. Cervin C, Lyssenko V, Bakhtadze E, et al. (2008) Genetic similarities between latent autoimmune diabetes in adults, type 1 diabetes, and type 2 diabetes. Diabetes 57:1433-1437
12. Lukacs K, Hosszufalusi N, Dinya E, Bakacs M, Madacsy L, Panczel P (2012) The type 2 diabetes-associated variant in TCF7L2 is associated with latent autoimmune diabetes in adult Europeans and the gene effect is modified by obesity: a meta-analysis and an individual study. Diabetologia 55:689-693
13. Groop L, Forsblom C, Lehtovirta M, et al. (1996) Metabolic consequences of a family history of NIDDM (the Botnia study): evidence for sex-specific parental effects. Diabetes 45:1585-1593
14. Isomaa B, Forsen B, Lahti K, et al. (2010) A family history of diabetes is associated with reduced physical fitness in the Prevalence, Prediction and Prevention of Diabetes (PPP)-Botnia study. Diabetologia 53:1709-1713
15. Thorn LM, Forsblom C, Fagerudd J, et al. (2005) Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). Diabetes Care 28:2019-2024
16. Lindholm E, Agardh E, Tuomi T, Groop L, Agardh CD (2001) Classifying diabetes according to the new WHO clinical stages. Eur J Epidemiol 17:983-989
17. Rolandsson O, Norberg M, Nystrom L, et al. (2012) How to diagnose and classify diabetes in primary health care: lessons learned from the Diabetes Register in Northern Sweden (DiabNorth). Scand J Prim Health Care 30:81-87
18. Berglund G, Elmstahl S, Janzon L, Larsson SA (1993) The Malmo Diet and Cancer Study. Design and feasibility. J Intern Med 233:45-51
19. Voight BF, Kang HM, Ding J, et al. (2012) The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits. PLoS Genet 8:e1002793
20. Morris AP, Voight BF, Teslovich TM, et al. (2012) Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet 44:981-990
21. Purcell S, Neale B, Todd-Brown K, et al. (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559-575
22. Grant SF, Thorleifsson G, Reynisdottir I, et al. (2006) Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 38:320-323
23. Zhou Y, Zhang E, Berggreen C, et al. (2012) Survival of pancreatic beta cells is partly controlled by a TCF7L2-p53-p53INP1-dependent pathway. Hum Mol Genet 21:196-207
24. Saxena R, Gianniny L, Burtt NP, et al. (2006) Common single nucleotide polymorphisms in TCF7L2 are reproducibly associated with type 2 diabetes and reduce the insulin response to glucose in nondiabetic individuals. Diabetes 55:2890-2895
25. Zampetti S, Spoletini M, Petrone A, et al. (2010) Association of TCF7L2 gene variants with low GAD autoantibody titre in LADA subjects (NIRAD Study 5). Diabet Med 27:701-704
26. Field SF, Howson JM, Smyth DJ, Walker NM, Dunger DB, Todd JA (2007) Analysis of the type 2 diabetes gene, TCF7L2, in 13,795 type 1 diabetes cases and control subjects. Diabetologia 50:212-213
27. Barrett JC, Clayton DG, Concannon P, et al. (2009) Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet 41:703-707
28. Dubois PC, Trynka G, Franke L, et al. (2010) Multiple common variants for celiac disease influencing immune gene expression. Nat Genet 42:295-302
29. Li X, Thyssen G, Beliakoff J, Sun Z (2006) The novel PIAS-like protein hZimp10 enhances Smad transcriptional activity. J Biol Chem 281:23748-23756
30. Lee J, Beliakoff J, Sun Z (2007) The novel PIAS-like protein hZimp10 is a transcriptional co-activator of the p53 tumor suppressor. Nucleic Acids Res 35:4523-4534
31. Luo X, Tarbell KV, Yang H, et al. (2007) Dendritic cells with TGF-beta1 differentiate naive CD4+CD25- T cells into islet-protective Foxp3+ regulatory T cells. Proc Natl Acad Sci U S A 104:2821-2826
32. Yoshimura A, Wakabayashi Y, Mori T (2010) Cellular and molecular basis for the regulation of inflammation by TGF-beta. J Biochem 147:781-792
33. Trudeau JD, Dutz JP, Arany E, Hill DJ, Fieldus WE, Finegood DT (2000) Neonatal beta-cell apoptosis: a trigger for autoimmune diabetes? Diabetes 49:1-7
34. Okamura S, Arakawa H, Tanaka T, et al. (2001) p53DINP1, a p53-inducible gene, regulates p53-dependent apoptosis. Mol Cell 8:85-94
35. Cho YS, Chen CH, Hu C, et al. (2011) Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians. Nat Genet 44:67-72
36. Qu HQ, Grant SF, Bradfield JP, et al. (2008) Association analysis of type 2 diabetes Loci in type 1 diabetes. Diabetes 57:1983-1986
37. Raj SM, Howson JM, Walker NM, et al. (2009) No association of multiple type 2 diabetes loci with type 1 diabetes. Diabetologia 52:2109-2116
38. Karamitri A, Renault N, Clement N, Guillaume JL, Jockers R (2013) Minireview: toward the establishment of a link between melatonin and glucose homeostasis: association of melatonin MT2 receptor variants with type 2 diabetes. Mol Endocrinol 27:1217-1233
39. Hardeland R (2013) Melatonin and the theories of aging: a critical appraisal of melatonin's role in antiaging mechanisms. J Pineal Res 55:325-356
40. Lyssenko V, Nagorny CL, Erdos MR, et al. (2009) Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet 41:82-88
41. Ramracheya RD, Muller DS, Squires PE, et al. (2008) Function and expression of melatonin receptors on human pancreatic islets. J Pineal Res 44:273-279
42. Bonnefond A, Clement N, Fawcett K, et al. (2012) Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. Nat Genet 44:297-301
43. Bradfield JP, Qu HQ, Wang K, et al. (2011) A genome-wide meta-analysis of six type 1 diabetes cohorts identifies multiple associated loci. PLoS Genet 7:e1002293
44. Vaxillaire M, Boccio V, Philippi A, et al. (1995) A gene for maturity onset diabetes of the young (MODY) maps to chromosome 12q. Nat Genet 9:418-423
45. Kathiresan S, Willer CJ, Peloso GM, et al. (2009) Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 41:56-65
46. Voight BF, Scott LJ, Steinthorsdottir V, et al. (2010) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 42:579-589
47. Odom DT, Zizlsperger N, Gordon DB, et al. (2004) Control of pancreas and liver gene expression by HNF transcription factors. Science 303:1378-1381